packageTofacitinib

tofacitinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Tofacitinib is a JAK inhibitor immunosuppressant used to treat rheumatoid arthritis and ulcerative colitis, and has also been studied for conditions such as alopecia areata. It is an approved medicine, authorised in the European Union for rheumatoid arthritis, and carries a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q3530324 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:tofacitinib
ATC codes:L04AF01
DrugBank:DB08895
PubChem CID:9926791
ChEBI:71200
Wikidata:Q3530324
formula:C16H20N6O
molar mass:312.377 g/mol (PubChem CID 9926791)
logP:1.5 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown